Neochem Bio Solutions Ltd
Incorporated in 2006, Neochem Bio Solutions Ltd. is engaged in the business of manufacturing of specialty performance chemicals.[1]
- Market Cap ₹ 118 Cr.
- Current Price ₹ 68.9
- High / Low ₹ 113 / 63.0
- Stock P/E 15.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 26.6 %
- ROE 46.4 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 32.2%
Cons
- Promoter holding has decreased over last quarter: -24.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 48.54 | 48.19 | 61.15 | 84.17 | |
| 45.03 | 43.89 | 55.03 | 71.36 | |
| Operating Profit | 3.51 | 4.30 | 6.12 | 12.81 |
| OPM % | 7.23% | 8.92% | 10.01% | 15.22% |
| 0.09 | 0.60 | 0.86 | 1.98 | |
| Interest | 1.28 | 2.10 | 2.96 | 3.51 |
| Depreciation | 1.04 | 1.22 | 1.22 | 1.33 |
| Profit before tax | 1.28 | 1.58 | 2.80 | 9.95 |
| Tax % | 25.00% | 27.85% | 31.07% | 25.23% |
| 0.97 | 1.14 | 1.93 | 7.44 | |
| EPS in Rs | 3.23 | 2.10 | 2.89 | 11.15 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 20% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 97% |
| TTM: | 285% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 32% |
| Last Year: | 46% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 3.00 | 5.43 | 6.68 | 6.68 |
| Reserves | 1.09 | 2.96 | 5.64 | 13.08 |
| 23.27 | 26.17 | 33.33 | 35.63 | |
| 19.02 | 16.11 | 17.81 | 22.99 | |
| Total Liabilities | 46.38 | 50.67 | 63.46 | 78.38 |
| 12.44 | 14.67 | 18.81 | 18.67 | |
| CWIP | 0.15 | 0.04 | 0.03 | 0.06 |
| Investments | 0.09 | 0.09 | 0.00 | 0.00 |
| 33.70 | 35.87 | 44.62 | 59.65 | |
| Total Assets | 46.38 | 50.67 | 63.46 | 78.38 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -1.46 | -0.97 | -0.64 | 2.20 | |
| -2.74 | -3.32 | 11.52 | 1.84 | |
| 4.33 | 3.95 | -10.57 | -4.33 | |
| Net Cash Flow | 0.12 | -0.34 | 0.30 | -0.30 |
| Free Cash Flow | -4.13 | -4.30 | 10.78 | 4.03 |
| CFO/OP | -36% | -23% | -10% | 17% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 102.49 | 107.25 | 100.28 | 107.93 |
| Inventory Days | 141.34 | 173.11 | 172.24 | 157.02 |
| Days Payable | 186.01 | 155.48 | 141.78 | 116.91 |
| Cash Conversion Cycle | 57.82 | 124.87 | 130.73 | 148.05 |
| Working Capital Days | 16.99 | 18.63 | 29.90 | 37.73 |
| ROCE % | 11.89% | 14.36% | 26.64% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Actual Production Volume MT |
|
||
| Capacity Utilization % |
|||
| Installed Production Capacity MTPA |
|||
| Number of Domestic Customers count |
|||
| Number of Export Countries count |
|||
| Number of Export Customers count |
|||
Documents
Announcements
-
Trading Window
30 March 2026 - Trading window closed from April 1, 2026 until 48 hours after audited results for year ended March 31, 2026.
-
Updates
21 March 2026 - Promoter Swapnil Rameshbhai Makati purchased 2,400 shares on 20 Mar 2026; holding 9,346,475 (54.57%).","checklist":["Review announcement and regulatory reference (SEBI PIT Reg 7(2))","Identify transacting party, shares, …
-
Updates
14 March 2026 - Promoter bought 2,400 shares on 13-Mar-2026; holding now 9,344,075 (54.57%).
-
Investor Presentation
5 March 2026 - Investor presentation: Red Herring Prospectus filed for proposed IPO; FY25 revenue ₹8,400 Lakhs; 22,000 MTPA capacity.
-
Analysts/Institutional Investor Meet/Con. Call Updates
5 March 2026 - Analyst/Institutional investor meeting on March 10, 2026 at Taj Santacruz, Mumbai (9:00 AM–6:00 PM); no UPSI.
Concalls
-
Mar 2026TranscriptAI SummaryPPT
Business Profile[1]
Operates as a specialty performance chemical company with 350+ customized formulations across four primary product segments, ''Polymers, Surfactants, Silicones and esters/bio-based sustainable solutions''.